Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

AACR 2009: Designer T-Cells tackle prostate cancer

AACR 2009

18 - 22 Apr 2009

Published: 30 Apr 2009

Views: 17500

Rating:

Save

Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA

Richard Junghans, M.D., Ph.D., associate professor of surgery and medicine, Boston University School of Medicine, presents at AACR 2009, Denver: Phase I Trial of Anti-PSMA Designer T Cells in Prostate Cancer. Cell footage in presentation copyright Cells Alive

Related Videos

Urinary markers in the surveillance setting of non-muscle invasive bladder...

Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer ( Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark )

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective...

Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC ( Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy )

EAU 2024: Bladder cancer latest

Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea...

EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi...

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer ( Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi Kitamura )

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Erdafitinib and current treatment landscape for advanced bladder cancer

Dr Yohann Loriot and Prof Arlene Siefker-Radtke

Erdafitinib and current treatment landscape for advanced bladder cancer ( Dr Yohann Loriot and Prof Arlene Siefker-Radtke )

Treatment sequencing for patients with mCRPC

Prof Axel Merseburger and Prof Stéphane Oudard

Treatment sequencing for patients with mCRPC ( Prof Axel Merseburger and Prof Stéphane Oudard )

Updates in bladder, kidney and testes cancer from ASCO 2022

Dr Winston Tan - Mayo Clinic, Jacksonville, USA

Updates in bladder, kidney and testes cancer from ASCO 2022 ( Dr Winston Tan - Mayo Clinic, Jacksonville, USA )

More from ecancer